Tricida, Inc. is a pharmaceutical company, which engages in the development and commercialization of orally administered polymer drugs for chronic kidney diseases. The company was founded by Gerrit Klaerner and Craig Jon Hawker on May 22, 2013 and is headquartered in Sacramento, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Tricida Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Tricida Inc market cap is $600.00.
What is the 52-week high for Tricida Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Tricida Inc 52 week high is $13.85 as of October 30, 2025.
What is the 52-week low for Tricida Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Tricida Inc 52 week low is $0.00 as of October 30, 2025.
What was Tricida Inc stock price yesterday?
Tricida Inc stock price yesterday was $0.01.
What is the PE ratio of Tricida Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Tricida Inc’s P/E ratio is 0.00.
What is the Price-to-Book ratio of Tricida Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Tricida Inc P/B ratio is 0.0000.
What is the 50-day moving average of Tricida Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Tricida Inc 50-day moving average is $0.0094.
